206 related articles for article (PubMed ID: 9785197)
1. Analysis of implantation in assisted reproduction through the use of serial human chorionic gonadotropin measurements.
Hsu MI; Kolm P; Leete J; Dong KW; Muasher S; Oehninger S
J Assist Reprod Genet; 1998 Sep; 15(8):496-503. PubMed ID: 9785197
[TBL] [Abstract][Full Text] [Related]
2. Is the timing of implantation affected by zona pellucida micromanipulation?
Hsu MI; Barroso G; Mayer J; Lanzendorf S; Gibbons WE; Muasher S; Oehninger S
J Assist Reprod Genet; 2000 Jan; 17(1):34-8. PubMed ID: 10754781
[TBL] [Abstract][Full Text] [Related]
3. Human chorionic gonadotropin levels in successful implantations after assisted reproduction techniques.
Ertzeid G; Tanbo T; Dale PO; Storeng R; Mørkrid L; Abyholm T
Gynecol Endocrinol; 2000 Aug; 14(4):258-63. PubMed ID: 11075296
[TBL] [Abstract][Full Text] [Related]
4. Ovarian stimulation protocol for in vitro fertilization with gonadotropin-releasing hormone agonist widens the implantation window.
Tur-Kaspa I; Confino E; Dudkiewicz AB; Myers SA; Friberg J; Gleicher N
Fertil Steril; 1990 May; 53(5):859-64. PubMed ID: 2110076
[TBL] [Abstract][Full Text] [Related]
5. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
[TBL] [Abstract][Full Text] [Related]
6. Maternal concentrations of human chorionic gonadotrophin in very early IVF pregnancies and duration of pregnancy: a follow-up study.
Tanbo TG; Zucknick M; Eskild A
Reprod Biomed Online; 2018 Aug; 37(2):208-215. PubMed ID: 29773310
[TBL] [Abstract][Full Text] [Related]
7. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
[TBL] [Abstract][Full Text] [Related]
8. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
[TBL] [Abstract][Full Text] [Related]
9. Serum progesterone concentrations on the day after human chorionic gonadotropin administration and progesterone/oocyte ratios predict in vitro fertilization/embryo transfer outcome.
Burns WN; Witz CA; Klein NA; Silverberg KM; Schenken RS
J Assist Reprod Genet; 1994 Jan; 11(1):17-23. PubMed ID: 7949830
[TBL] [Abstract][Full Text] [Related]
10. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
[TBL] [Abstract][Full Text] [Related]
11. Maternal hCG concentrations in early IVF pregnancies: associations with number of cells in the Day 2 embryo and oocytes retrieved.
Tanbo TG; Eskild A
Hum Reprod; 2015 Dec; 30(12):2758-63. PubMed ID: 26508733
[TBL] [Abstract][Full Text] [Related]
12. Association of early beta-human chorionic gonadotrophin values with pregnancy wastage and multiple implantation in a donor oocyte programme.
Legro RS; Paulson RJ; Lobo RA; Sauer MV
Hum Reprod; 1995 Dec; 10(12):3293-6. PubMed ID: 8822461
[TBL] [Abstract][Full Text] [Related]
13. Comparison of implantation and early development of human embryos fertilized in vitro versus in vivo using transvaginal ultrasound.
Pellicer A; Calatayud C; Miró F; Castellvi RM; Ruiz A; Ruiz M; Pérez M; Bonilla-Musoles F
J Ultrasound Med; 1991 Jan; 10(1):31-5. PubMed ID: 1900086
[TBL] [Abstract][Full Text] [Related]
14. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
[TBL] [Abstract][Full Text] [Related]
15. Failed oocyte retrieval after lack of human chorionic gonadotropin administration in assisted reproductive technology.
Asch RH; Li HP; Yovich JL; Katayama KP; Balmaceda JP; Rojas FJ; Stone SC
Fertil Steril; 1992 Aug; 58(2):361-5. PubMed ID: 1633903
[TBL] [Abstract][Full Text] [Related]
16. Falling estradiol levels on day after human chorionic gonadotropin administration in assisted reproductive technology cycles are not predictive of decreasing oocyte maturity or pregnancy rates.
Levy G; Hill M; Beall S; Pilgrim JD; Payson M; Propst A
J Reprod Med; 2014; 59(5-6):255-9. PubMed ID: 24937966
[TBL] [Abstract][Full Text] [Related]
17. Delayed embryo implantation following in vitro fertilization and embryo transfer (IVFET).
Tulchinsky D; Tulchinsky A; Paoletti-Falcone V; Nash H; Pazdziorko S; Brown K
J Assist Reprod Genet; 1996 Aug; 13(7):536-9. PubMed ID: 8844308
[TBL] [Abstract][Full Text] [Related]
18. GnRH agonist trigger with intensive luteal phase support vs. human chorionic gonadotropin trigger in high responders: an observational study reporting pregnancy outcomes and incidence of ovarian hyperstimulation syndrome.
Christopoulos G; Vlismas A; Carby A; Lavery S; Trew G
Hum Fertil (Camb); 2016 Sep; 19(3):199-206. PubMed ID: 27662416
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycosylated human chorionic gonadotropin as a predictor of ongoing pregnancy.
Brady PC; Farland LV; Racowsky C; Ginsburg ES
Am J Obstet Gynecol; 2020 Jan; 222(1):68.e1-68.e12. PubMed ID: 31401260
[TBL] [Abstract][Full Text] [Related]
20. Abnormal human chorionic gonadotropin (hCG) trends after transfer of multiple embryos resulting in viable singleton pregnancies.
Brady PC; Farland LV; Missmer SA; Racowsky C; Fox JH
J Assist Reprod Genet; 2018 Mar; 35(3):483-489. PubMed ID: 29260358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
